← All trials
NCT01066052
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 29, 1992
- Primary completion
- Mar 31, 1999
- Completion date
- Aug 31, 2010
- First posted
- Feb 10, 2010
- Last posted
- Dec 14, 2018
- Enrollment
- 115
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Merck KGaALead sponsor
- Merck KGaAStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.